| Patents for C07J 17 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta[a]hydrophenanthrene skeleton (2,111) |
|---|
| 09/19/2002 | WO2002072599A1 Anti-apoptosis agents or regeneration promoters comprising ginsenosides |
| 09/18/2002 | CN1370180A Conjugates of phytosterol or phytostanol with ascorbic acid and use thereof in treating or preventing cardiovascular disease |
| 09/12/2002 | WO2002069977A1 Use of certain steroids for treatment of blood cell deficiencies |
| 09/12/2002 | CA2439687A1 Use of certain steroids for treatment of blood cell deficiencies |
| 09/04/2002 | EP1235849A2 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 09/03/2002 | US6444683 17-azolyl steroids useful as androgen synthesis inhibitors |
| 09/03/2002 | US6444649 Solid dispersion which comprises sialic acid derivative dispersed in water-soluble macromolecule |
| 08/29/2002 | WO2001032679A9 Novel glycosides comprising pentose mono-, di-, tri-, or oligosaccharides and phytosterols and/or phytostanols |
| 08/22/2002 | US20020115623 Saponin derivatives useful for inhibiting sialyltransferase and biosynthesis of sialoglycoconjugate |
| 08/14/2002 | EP1189922A4 Steroid derivatives |
| 08/08/2002 | WO2002019971A9 4-halogenated 17-methylene steroids, method for the production thereof and pharmaceutical compositions containing these compounds |
| 08/01/2002 | US20020103392 Corticoid-17,21-dicarboxylic esters and corticosteroid 17-carboxylic ester 21-carbonic esters, processes for their preparation and pharmaceuticals containing these compounds |
| 07/31/2002 | EP1226154A1 Estradiol conjugates and uses thereof |
| 07/24/2002 | EP1223941A2 Therapeutic treatments comprising administratoin of certain steroids for blood cell deficiencies |
| 07/24/2002 | CN1360590A Androgen glycosides and androgenic activity thereof |
| 07/23/2002 | US6423698 Combination therapy for the prophylaxis and/or treatment of benign prostatic hyperplasia |
| 07/18/2002 | WO2002055531A1 Conjugates of immune cell specific macrolide compounds with anti-inflammatory compounds for improved cellular targeting of anti-inflammatory therapy |
| 07/18/2002 | WO2002055529A2 A process for isolating saponins from soybean-derived materials |
| 07/17/2002 | EP1222927A2 Pharmaceutical compositions having appetite suppressant activity |
| 07/03/2002 | CN1357003A 类固醇衍生物 Steroid derivatives |
| 06/26/2002 | CN1355809A Immunomodulatory steroids, in particular hemihydrate of 16 alpha-bromoepiandrosterone |
| 06/13/2002 | US20020071815 Antipsoriatic nail polish |
| 06/12/2002 | EP1213026A1 Brain cell or nerve cell protecting agents comprising ginseng |
| 06/12/2002 | EP1213020A2 Pharmaceutical compositions having appetite suppressant activity |
| 06/06/2002 | DE10045961A1 New colossolactone triterpene compounds, useful as antiinflammatory agents, isolated from mycelium or fruiting bodies of Ganoderma colossum |
| 06/04/2002 | US6399767 Intermediates for the synthesis of vitamin D and steroid derivatives and process for preparation thereof |
| 05/30/2002 | WO2001042273A3 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 05/30/2002 | US20020065257 17beta-amino and hydroxylamino-11beta-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
| 05/22/2002 | EP0606317B1 Saponin-antigen conjugates and the use thereof |
| 05/16/2002 | WO2002038166A2 Ginseng berry extracts and pharmaceutical compositions therefrom |
| 05/08/2002 | CN1348461A 17 beta-acyl-17 alpha-propynyl-11 beta-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
| 05/02/2002 | EP1201242A2 Use of mometasone furoate in an adjuvant therapy |
| 05/02/2002 | EP1200131A2 Compositions and methods for targeted enzymatic release of cell regulatory compounds |
| 05/02/2002 | EP0615448B1 Sex steroid activity inhibitors |
| 04/30/2002 | US6380167 Methods for anti-tumor therapy |
| 04/23/2002 | US6376657 Pharmaceutical compositions having appetite suppressant activity |
| 04/17/2002 | EP0740550B1 Use of mometasone furoate for treating airway passage and lung diseases |
| 04/04/2002 | DE10043846A1 17-Methylensteroide, Verfahren zu deren Herstellung und diese Verbindung enthaltende pharmazeutische Zusammensetzungen 17-methyl steroids, processes for their preparation and pharmaceutical compositions containing this compound |
| 04/03/2002 | EP1192946A1 Use of mometasone furoate for treating airway passage and lung diseases |
| 03/28/2002 | WO2002000679A3 9.alpha.-chloro-6.alpha.-fluoro-17.alpha.-hydroxy-16-methyl-17-beta-methoxycarbonyl-androst-1,4-dienes esterified in position 17.alpha. by a cyclic acyl group |
| 03/27/2002 | EP1189924A1 Conjugates of phytosterol or phytostanol with ascorbic acid and use thereof in treating or preventing cardiovascular disease |
| 03/27/2002 | EP1189922A1 Steroid derivatives |
| 03/12/2002 | US6355816 Process for isolating saponins from soybean-derived materials |
| 03/06/2002 | EP0723551B1 Hapten-marked peptides |
| 03/05/2002 | US6352686 Antipsoriatic nail polish |
| 02/27/2002 | CN1079666C Dermatological preparation |
| 02/14/2002 | WO2002012266A1 17.beta.-carbothioate 17.alpha.-arylcarbonyloxyloxy androstane derivative as anti-inflammatory agents |
| 02/14/2002 | WO2002012265A1 6.ALPHA., 9.ALPHA.-DIFLUORO-17.ALPHA.-`(2-FURANYLCARBOXYL) OXY!-11.BETA.-HYDROXY-16.ALPHA.-METHYL-3-OXO-ANDROST-1,4,-DIENE-17-CARBOTHIOIC ACID S-FLUOROMETHYL ESTER AS AN ANTI-INFLAMMATORY AGENT |
| 02/14/2002 | WO2001030802A3 Therapeutic treatments comprising administration of certain steroids for blood cell deficiencies |
| 02/14/2002 | US20020019378 Compounds |
| 02/14/2002 | CA2634715A1 6.alpha.,9.alpha.-difluoro-17.alpha.-[(2-furanylcarboxyl)oxy}-11.beta.-hydroxy-16.alpha-methyl-3-oxo-androsta-1,4-diene-17.beta.carbothioic acids-fluoromethyl ester as an anti-inflammatory agent |
| 02/14/2002 | CA2417826A1 17.beta.-carbothioate 17.alpha.-arylcarbonyloxyloxy androstane derivative as anti-inflammatory agents |
| 02/06/2002 | CN1334738A Cerebrovascular regeneration/reconstruction promoters and nerve tissue secondary degeneration inhibitors comprising ginsenoside Rb1 |
| 01/31/2002 | WO2002008243A1 Oxidation process for preparing the intermediate 6.alpha.,9.alpha.-difluoro-11.beta.,17.alpha.-dihydroxy-16.alpha.-methyl-androst-1,4-dien-3-one 17.beta.-carboxylic acid |
| 01/31/2002 | CA2406963A1 Oxidation process for preparing the intermediate 6.alpha.,9.alpha.-difluoro-11.beta.,17.alpha.-dihydroxy-16.alpha.-methyl-androst-1,4-dien-3-one 17.beta.-carboxylic acid |
| 01/30/2002 | EP1175433A1 Androgen glycosides and androgenic activity thereof |
| 01/23/2002 | EP1174139A2 Use of mometasone furoate for treating airway passage and lung diseases |
| 01/23/2002 | EP1174138A2 Use of mometasone furoate for treating airway passage and lung diseases |
| 01/16/2002 | CN1331698A Brain cell or nerve cell-protective agents comprising ginsenoside Rb1 |
| 01/09/2002 | EP1170012A1 Cerebrovascular regeneration/reconstruction promoters and nerve tissue secondary degeneration inhibitors comprising ginsenoside rb 1? |
| 01/09/2002 | CN1330659A Pregnane glucuronides compound |
| 01/03/2002 | WO2002000679A2 9.alpha.-chloro-6.alpha.-fluoro-17.alpha.-hydroxy-16-methyl-17-beta-methoxycarbonyl-androst-1,4-dienes esterified in position 17.alpha. by a cyclic acyl group |
| 01/03/2002 | US20020002141 For inhibiting apoptosis or apoptosis-like cell death |
| 01/02/2002 | EP1167364A1 Benzopyran-containing compounds and prodrug forms thereof |
| 12/27/2001 | WO2001098322A1 Novel steroidal antiestrogens and antiandrogens and uses thereof |
| 12/19/2001 | EP1163256A1 Immunomodulatory steroids, in particular the hemihydrate of 16.alpha.-bromoepiandrosterone |
| 12/19/2001 | EP0717985B1 Dermatologic preparation |
| 12/06/2001 | WO2001092289A1 SKIN TISSUE REGENERATION PROMOTERS COMPRISING GINSENOSIDE Rb1 |
| 12/05/2001 | EP1142903A9 BRAIN CELL OR NERVE CELL-PROTECTIVE AGENTS COMPRISING GINSENOSIDE Rb 1? |
| 12/05/2001 | EP0749437B1 Pharmaceutical uses of steroid derivatives |
| 12/05/2001 | CN1325308A Use of neurotrophic factor stimulators for treatment of ophthalmic neurodegenerative diseases |
| 11/28/2001 | EP0906332B1 7alpha-(5-methylaminopentyl)-estratrienes, process for the preparation thereof, pharmaceutical preparations which contain said 7alpha-(5-methylaminopentyl)-estratrienes and use thereof for production of drugs |
| 11/27/2001 | CA2025294C Bile acid derivatives, processes for their preparation, and use as pharmaceuticals |
| 11/08/2001 | US20010038864 Extracting betulinic acid from the bark of plane tree with a solvent, inspissating the extracts, and recrystallizing the obtained betulinic acid; useful as anticancer agent and amides thereof as anti-HIV agents |
| 11/07/2001 | EP1150687A2 Methods for anti-tumor therapy |
| 11/06/2001 | CA2218724C Metabolites of ginseng saponins by human intestinal bacteria and its preparation for an anticancer |
| 10/25/2001 | WO2001079256A1 19-norbufalin derivatives, their preparation and pharmaceutical compositions containing them |
| 10/25/2001 | WO2001032679A3 Novel glycosides comprising pentose mono-, di-, tri-, or oligosaccharides and phytosterols and/or phytostanols |
| 10/23/2001 | CA2226140C Compounds for treating or preventing osteoporosis and symptoms associated with menopause |
| 10/10/2001 | EP1142903A1 BRAIN CELL OR NERVE CELL-PROTECTIVE AGENTS COMPRISING GINSENOSIDE Rb 1? |
| 10/10/2001 | EP1140972A1 New 7-alpha, 17-alpha-bis-alkylated testosterone derivatives and their use in long-term therapy of androgen-dependent diseases |
| 09/26/2001 | EP1135403A1 17beta-acyl-17alpha-propynyl-11beta-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
| 09/26/2001 | EP1135134A1 Use of neurotrophic factor stimulators for the treatment of ophthalmic neurodegenerative diseases |
| 09/11/2001 | US6288051 Estrogen-dependent breast cancer treatment |
| 08/21/2001 | US6277838 Methods for allosteric modulation of the GABA receptor by members of the androstane and pregnane series |
| 08/08/2001 | EP1121376A1 Pregnane glucuronides |
| 08/01/2001 | CN1306432A Deoxy and oxygen-substituted sugar-contg. 14-aminosteriod compounds for use as antiarrhythmic |
| 07/25/2001 | CN1305489A Solid dispersion containing sialic acid derivative |
| 07/19/2001 | WO2001002020A3 Compositions and methods for targeted enzymatic release of cell regulatory compounds |
| 07/17/2001 | US6262042 17β-amino and hydroxylamino-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
| 07/12/2001 | WO2001049704A1 Compound (i), a method for extracting it and a pharmaceutical composition containing it |
| 07/11/2001 | CN1303391A 17 Beta-amino and hydroxylamino-11 beta-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
| 07/11/2001 | CN1302811A Compound (I), extraction process and its application in preparing medicine to cure acute ischemic cerebrovascular disease |
| 07/05/2001 | US20010006625 Comprising one or more glucocorticoids, physiologicall tolerable solvent(s), and water insoluble film-forming agents |
| 06/14/2001 | WO2001042273A2 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 06/13/2001 | EP1105408A1 Congugates of dna interacting groups with steroid hormones for use as nucleic acid transfection agents |
| 05/15/2001 | CA2173729C .delta.16 unsaturated c17 heterocyclic steroids useful as steroid c17-20 lyase inhibitors |
| 05/10/2001 | WO2001032679A2 Novel glycosides comprising pentose mono-, di-, tri-, or oligosaccharides and phytosterols and/or phytostanols |
| 05/10/2001 | US20010001099 For treatment of prostate cancer and benign prostatic hypertrophy |
| 05/10/2001 | CA2389670A1 Novel glycosides comprising pentose mono-, di-, tri-, or oligosaccharides and phytosterols and/or phytostanols |